{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:58:50Z","timestamp":1770994730398,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"7-8","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:p>The spread of synthetic cathinone injecting is a new phenomenon observed in recent years in Hungary. Until 2010, when the first anecdotal reports on cathinone injecting appeared, injecting was associated with the use of heroin and amphetamine. In this paper we review available evidence of the changes in the drug market and a concurrent shift in patterns of injecting drug use that have been taking place in Hungary since 2010. Remarkable changes have been observed in police seizures data since 2010. While new psychoactive substances have appeared, the availability of heroin has dropped significantly. A qualitative study in 2011 revealed that these market changes correlate with changes in patterns of injecting drug use: decreasing heroin use and the appearance of mephedrone injecting were reported by treatment and needle and syringe programme (NSP) personnel. These changes are detectable in other routine epidemiological data collection systems in the following years as well (i.e. treatment, drug\u2010related deaths, NSP clientele). Heroin\u2010related treatment demand dropped, as did heroin\u2010related mortality. Parallel to this, a growing number of clients appeared in treatment and in NSPs who were primarily injecting cathinones. The shift to cathinones can be observed in amphetamine and heroin injectors as well. Monitoring changes in patterns of injecting drug use are especially important because of the vulnerability of this drug\u2010user population and the consequences of this high\u2010risk route of drug administration. The realignment observed in Hungary is to be further investigated with regard to its determinants, changes in risk behaviour, and in treatment needs. Copyright \u00a9 2014 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/dta.1625","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T15:41:56Z","timestamp":1396366916000},"page":"825-831","source":"Crossref","is-referenced-by-count":34,"title":["Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones"],"prefix":"10.1002","volume":"6","author":[{"given":"Anna","family":"P\u00e9terfi","sequence":"first","affiliation":[{"name":"Hungarian National Focal Point (REITOX) National Centre for Epidemiology  2\u20106 Albert Fl\u00f3ri\u00e1n \u00fat 1097 Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tarj\u00e1n","sequence":"additional","affiliation":[{"name":"Hungarian National Focal Point (REITOX) National Centre for Epidemiology  2\u20106 Albert Fl\u00f3ri\u00e1n \u00fat 1097 Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely Csaba","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Hungarian National Focal Point (REITOX) National Centre for Epidemiology  2\u20106 Albert Fl\u00f3ri\u00e1n \u00fat 1097 Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Csesztregi","sequence":"additional","affiliation":[{"name":"Hungarian Institute for Forensic Sciences  9 Mosonyi utca 1087 Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienn","family":"Ny\u00edr\u00e1dy","sequence":"additional","affiliation":[{"name":"Hungarian National Focal Point (REITOX) National Centre for Epidemiology  2\u20106 Albert Fl\u00f3ri\u00e1n \u00fat 1097 Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"EMCDDA.European Drug Report 2013: Trends and developments. Publications Office of the European Union Luxembourg 2013."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113480987"},{"key":"e_1_2_5_4_1","unstructured":"V.A.Gyarmathy A.Neaigus B.Feh\u00e9r E.Ujhelyi J.R\u00e1cz.HIV Prevalence and Syringe Sharing among Young Drug Injectors in Budapest Hungary. Poster Exhibition: The XIV International AIDS Conference: Abstract No.MoPeC3407 Barcelona 2002 7\u201312\/7\/2002."},{"key":"e_1_2_5_5_1","unstructured":"Hungarian National Focal Point.National Report 2010 2010 pp.40\u201342; 42\u201344; 163\u2013165. Available at:http:\/\/drogfokuszpont.hu\/wp\u2010content\/uploads\/nr_10_en.pdf[2 September 2013]."},{"key":"e_1_2_5_6_1","first-page":"97","article-title":"A probl\u00e9m\u00e1s drogfogyaszt\u00e1s elterjedts\u00e9g\u00e9nek becsl\u00e9se fog\u00e1s\u2010visszafog\u00e1s m\u00f3dszerrel","volume":"6","author":"Elekes Z.","year":"2007","journal-title":"Addictologia Hungarica"},{"key":"e_1_2_5_7_1","unstructured":"Hungarian Institute for Forensic Sciences.Monitoring newsletter 2011\/II. Available at:http:\/\/www.bszki.hu\/e107_files\/downloads\/MH2011II.pdf[2 September2013]."},{"key":"e_1_2_5_8_1","first-page":"281","article-title":"Magyarorsz\u00e1gi intrav\u00e9n\u00e1s mefedronhaszn\u00e1lat a t\u0171csere szolg\u00e1ltat\u00f3k tapasztalatai alapj\u00e1n","volume":"9","author":"Cs\u00e1k R.","year":"2010","journal-title":"Addictologia Hungarica"},{"key":"e_1_2_5_9_1","first-page":"29","article-title":"A drogv\u00e1lt\u00e1s jelens\u00e9ge injekci\u00f3s droghaszn\u00e1l\u00f3kkal k\u00e9sz\u00fclt interj\u00fakban","volume":"27","author":"R\u00e1cz J.","year":"2012","journal-title":"Psychiatr. Hung."},{"key":"e_1_2_5_10_1","unstructured":"Hungarian National Focal Point.Drug\u2010related treatment \u2013 Facts and figures. Available at:http:\/\/drogfokuszpont.hu\/eves\u2010jelentesek\/?lang=en[2 November2013]."},{"key":"e_1_2_5_11_1","unstructured":"EMCDDA.Drug\u2010Related Deaths (DRD) Standard Protocol version 3.2 2009. EMCDDA Lisbon 2009. Available at:http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_107408_EN_DRD%20Standard%20Protocol%20version%203.2.pdf[18 November 2013]."},{"key":"e_1_2_5_12_1","unstructured":"R.Simon T.Pfeiffer T.Hartnoll J.Vicente C.Luckett M.Stauffacher.The Treatment Demand Indicator (TDI) Standard Protocol 2.0. EMCDDA Lisbon 2000."},{"key":"e_1_2_5_13_1","unstructured":"SPSS for Windows 16.0.1[computer software]. Chicago Illinois: SPSS Inc.2007."},{"key":"e_1_2_5_14_1","first-page":"70","volume-title":"Early warning system \u2013 national profiles","author":"P\u00e9terfi A.","year":"2012"},{"key":"e_1_2_5_15_1","unstructured":"Hungarian National Focal Point.National Report 2011 2011 pp.83\u201395. Available at:http:\/\/drogfokuszpont.hu\/wp\u2010content\/uploads\/national_report_2011_hungary.pdf[2 November 2013]."},{"key":"e_1_2_5_16_1","unstructured":"Hungarian National Focal Point.National Report 2012 2012 pp.16\u201321 93\u2010104. Available at:http:\/\/drogfokuszpont.hu\/wp\u2010content\/uploads\/HU_National_Report_2012.pdf[2 November 2013]."},{"key":"e_1_2_5_17_1","unstructured":"Hungarian National Focal Point.National Report 2013 2013 pp.96\u2013109. Available at:http:\/\/drogfokuszpont.hu\/wp\u2010content\/uploads\/HU_National_Report_2013.pdf[2 November 2013]."},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2297"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03829.x"},{"key":"e_1_2_5_20_1","unstructured":"EMCDDA.Perspectives on drugs. Trends in heroin use in Europe: what do treatment demand data tell us?Lisbon 2013. Available at:http:\/\/www.emcdda.europa.eu\/topics\/pods\/trends\u2010in\u2010heroin\u2010use[2 September 2013]."},{"key":"e_1_2_5_21_1","unstructured":"UNODC.World Drug Report 2012 United Nations Office on Drugs and Crime Vienna 2012."},{"key":"e_1_2_5_22_1","unstructured":"EMCDDA.Table SZR\u20107. Number of heroin seizures 1995\u20132011.Statistical Bulletin 2013. EMCDDA Lisbon 2013. Available at:http:\/\/www.emcdda.europa.eu\/stats13#display:\/stats13\/szrtab7[2 November 2013]."},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00013-9"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01094.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2005.05.008"},{"key":"e_1_2_5_26_1","unstructured":"EMCDDA Europol.New drugs in Europe 2012. EMCDDA\u2010Europol2012 Annual Report on the implementation of Council Decision 2005\/387\/JHA. Publications Office of the European Union Luxembourg 2012."},{"key":"e_1_2_5_27_1","volume-title":"Sociological Methods: A Sourcebook","author":"Denzin N.K.","year":"2006"},{"key":"e_1_2_5_28_1","unstructured":"A.Botescu A.Abagiu M.Mardarescu M.Ursan.HIV\/AIDS among injecting drug users in Romania \u2010 report of a recent outbreak and initial response policies. EMCDDA Lisbon 2012. Available at:http:\/\/www.emcdda.europa.eu\/publications\/ad\u2010hoc\/2012\/romania\u2010hiv\u2010update[2 September 2013]."},{"key":"e_1_2_5_29_1","unstructured":"Agen\u0163ia Na\u0163ionala Antidrog.Situa\u0163ia droguliror \u00een Rom\u00e2nia \u00een anul 2012 \u2013 Sintez\u00e2 2013. Available at:http:\/\/www.ana.gov.ro\/rapoarte%20nationale\/Sinteza%20ANA%202013.pdf[2 September 2013]."},{"key":"e_1_2_5_30_1","unstructured":"EMCDDA.Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. EMCDDA Lisbon 2011."},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2012.01.008"}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdta.1625","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.1625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:19:32Z","timestamp":1760368772000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.1625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":30,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1002\/dta.1625"],"URL":"https:\/\/doi.org\/10.1002\/dta.1625","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}